About
Our Science
News & Media
Careers
Contact Us
JP
/
EN
About
Vision, Mission, and Values
Message from the CEO
Corporate Overview
Leadership Team
Company Name & Logo
Access / Location
Our Science
Development Pipeline
Cancer Detection
Multi-Cancer Early Detection
SMA/SCID
Biological Age Assessment
Bio AI
Clinical Studies
Publications
News & Media
All
Press
Research
Media
Award
News
Careers
Contact Us
News & Media
All
→
Press
→
Research
→
Media
→
Award
→
News
All
Loading...
All
Media
Craif Featured by CNA Among Asia's Next Wave of AI Startups Moving Into the Real World
2026.10.01
Press
Craif to Exhibit in Japan's Cabinet Office Startup Booth at BioJapan 2026; COO Mika Mizunuma to Speak on Bio-AI for Pre-Disease Health
2026.09.30
Media
Nikkei Reports on Craif's Plan to Sell Its Laboratory Operations Know-How Through Oyster Lab OS
2026.09.24
Press
Craif Founds Japan's Bio-AI Association (BAIA); COO Mika Mizunuma Named Chair
2026.09.18
Press
Craif Launches miAge, a 19,800 Yen Urine Test That Estimates Biological Age Across Five Organ Systems
2026.09.17
Press
Craif Launches Oyster Lab OS, the Lab System Behind Five Straight Years of Zero Audit Findings
2026.09.17
Press
Craif Completes Enrollment and Sample Collection in the Pivotal Trial of Its Urinary microRNA Software Device for Pancreatic Cancer
2026.09.17
Press
Craif Opens Oyster Platform, the Development Platform It Runs Its Own Company On, to Outside Users
2026.09.17
Press
Craif Receives Japan's Highest-Tier Medical Device Marketing Authorization License, a Required Step Toward Commercializing Its Pancreatic Cancer Diagnostic Aid
2026.09.17
Press
Bio-AI Summit 2026 Convenes in Tokyo, with Tokyo Vice Governor Manabu Miyasaka and Craif Chief Medical Officer Nick Bevins Among the Speakers
2026.09.14
1
2
3
4
5
Last
